Concepedia

Publication | Open Access

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients

DOIFull Paper Access

20

Citations

29

References

2015

Year

Rositsa Koleva‐Kolarova, Marcel J. W. Greuter, Michel van Kruchten, Karin M. Vermeulen, Talitha Feenstra, Erik Buskens, Andor W.J.M. Glaudemans, Erik F. J. de Vries, Elisabeth G.E. de Vries, Geke A.P. Hospers,
British Journal of Cancer

Abstract

The number of performed biopsies was lower in the FES-PET/CT strategy at an ICER of 12.1 ± 3.4 thousand Euro per biopsy avoided, whereas the application of the FDG-PET/CT did not reduce the number of biopsies and was more expensive. Whether the FES-PET/CT strategy has additional benefits for patients in terms of therapy management has to be evaluated in clinical studies.

References

YearCitations

Page 1